UK Markets closed

MorphoSys AG (MOR.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
20.61-0.51 (-2.41%)
At close: 05:35PM CEST
Full screen
Previous close21.12
Open20.88
Bid0.00 x 1500
Ask0.00 x 8800
Day's range20.08 - 21.20
52-week range16.45 - 51.60
Volume270,543
Avg. volume171,039
Market cap703.646M
Beta (5Y monthly)0.87
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results

    DGAP-News: MorphoSys AG / Key word(s): Half Year ResultsMorphoSys AG Reports Second Quarter and First Half 2022 Financial Results 03.08.2022 / 22:01 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, August 3, 2022MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results Monjuvi® U.S. net product sales of US$ 23.3 million (€ 21.7 million) for the second quarter 2022, a 25% Q-Q growth and 29% Y-Y growth Efficacy and safety d

  • EQS Group

    MorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022

    DGAP-News: MorphoSys AG / Key word(s): Half Year ResultsMorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022 28.07.2022 / 22:03 The issuer is solely responsible for the content of this announcement. Conference Call AlertPlanegg/Munich, Germany, July 28, 2022 Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4, 2022 MorphoSys AG (FSE: MOR; NASDAQ: MOR) will publish its results for

  • EQS Group

    MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

    DGAP-News: MorphoSys AG / Key word(s): Change in ForecastMorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022 26.07.2022 / 11:16 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, July 26, 2022 MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022 Preliminary Q2 2022 Monjuvi U.S. net product sales of US$ 23.3 million (€ 21.7 million) Update of financial